1. Revealed: The top 100 cited antibodies of 2016

    New data from CiteAb reveals that just nine companies supply the top 100 antibodies cited over the whole of 2016. In addition, one single company is responsible for the supply of 38 of these antibodies. Dr Andrew Chalmers, founder of CiteAb, said: “This data comes from a set that shows trends in citation rates for […]

  2. Have you seen our widget in action on distributor sites?

    Exciting news – this week our citation widget has been put into use for the first time on a distributor website. Previously a number of suppliers have used our citation widget on their websites, including Cell Signaling Technologies, US Biological, Rockland Immunochemicals and Bethyl Laboratories. We also provided our first ELISA citation widget to Active […]

  3. New data – top custom antibody targets

    Following our blog last week about our new custom antibody dataset, today we’re going to look at this data in a little more detail, focusing on the top targets for custom antibodies. Our custom antibody data helps suppliers identify antibodies to license in, but also gives us a great insight to trends in the market. […]

  4. Who is the most popular custom antibody supplier?

    In a first for CiteAb, today we’re taking a first look at the global custom antibody market and we’ll be highlighting those suppliers claiming the largest share. CiteAb founder Dr Andrew Chalmers said: “As you know, we specialise in collating citations for catalogue antibodies, however over the last few months our team has been taking […]

  5. Thank you to our 50k monthly users!

    Great news – you’re here using CiteAb and you’re in really good company. A lot of it! The CiteAb user base has grown and grown, and we are now helping over 50,000 users like you to find quality antibodies every month. In addition, we have now got over a million citations listed in the CiteAb […]

  6. Catch up on your free data!

    Over recent weeks we’ve covered loads of different data stories here on our blog and have given away free data with each of them. We thought it might be helpful to provide a quick recap, and links to help you collect any of the free data sets you might have missed out on. We reported […]

  7. Top antibodies used to understand prostate cancer

    Last week we reported on our brand new text mining technology developed by our team here at CiteAb. Today we’re looking at some very specific data we can access as a result of this new technology – insights into the antibodies used in prostate cancer research. CiteAb developer Matt Helsby said: “Using this new text […]

  8. New text mining tech gives autophagy insights

    We recently told you that we have some tech updates in the pipeline – and today we are going to speak to one of our developers, Matt Helsby, to show you a new piece of tech we’ve created. So Matt, what’s new? “Hi there! Today we’re launching an update to our text mining technology which […]

  9. Fake antibodies cause stir in Chinese market

    Last week we reported on the continued fast paced growth of the Chinese antibody market, and mentioned that this has not been without its perils. Today we’re going to take a look at the lucrative market for fake research reagents that has arisen in China and was recently exposed by science journal Nature. Nature reports […]

  10. Chinese antibody market powers ahead

    Today we return to our first ever data report, released three years ago, when we claimed that China was a market no supplier could ignore, and we look at new data to see whether our predictions came true. Back in 2014 we stated that ‘the data suggests that China is set to claim the lion’s […]